Pro-Dex: Still A Buy, But Don’t Chase (NASDAQ:PDEX)
· seekingalpha.com
Pro-Dex sales rose 14.6% to $19.9M, with the APM acquisition and contract extensions driving 2028 growth. Learn why PDEX stock is a buy.
Pro-Dex, Inc. ( PDEX ) is a specialized medical instrument manufacturer that develops surgical handpieces. These items are often useful for orthopedic, thoracic...